Bush Keeps Klausner As NCI Director; Senate Confirms Thompson For HHS.
Golde To Step Down As Physician-in-Chief At Memorial Sloan-Kettering Next Year.
Golde To Step Down At MSK; Porter Joins Hogan & Hartson.
FASEB Calls For 15% Increase For NIH Next Fiscal Year.
Holden Center At U. Of Iowa Designated Comprehensive.
Obit: George Santos, Hopkins Cancer Treatment Pioneer.
Course On Human Research Protections Goes Online @ Cancer.Gov.
FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.
NCCN Updates Treatment Guidelines To Include CEF For Early Breast Cancer.
US Oncology To Participate In Firm’s Ovarian Cancer Trial.
Atrix, Sanofi In Marketing Deal For Leuprogel Products.
Trending Stories
- Duke brain cancer researcher Kyle Walsh named director of NIEHS
- Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding
- GRAIL to use new study results to seek FDA approval of Galleri MCD test
- Ross Levine named chief scientific officer of Memorial Sloan Kettering Cancer Center
- Cliff Hudis on how AI in cancer care is “inevitable”—and ASCO is working to make it safer
- Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research









